Familial Sarcoma: Challenging Pedigrees

Cancer

Volumn 98, Issue 9, 2003, Pages 1947-1957

  Lynch, Henry T ^a   Deters, Carolyn A ^a   Hogg, David ^b   Lynch, Jane F ^a   Kinarsky, Yulia ^a   Gatalica, Zoran ^c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genetic counseling; Germline mutations; Osteogenic sarcoma; Phenotypic and genotypic heterogeneity; Soft tissue sarcoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; COLORECTAL CANCER; EARLY DIAGNOSIS; FAMILIAL CANCER; FAMILIAL SARCOMA; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENOTYPE; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; OSTEOSARCOMA; PEDIGREE; PRIORITY JOURNAL; PROGNOSIS; SARCOMA;

ADULT; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; OSTEOSARCOMA; PEDIGREE; PHENOTYPE; SARCOMA;

EID: 0142243197     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11743     Document Type: Article

References (84)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. Zahm SH, Fraumeni JF Jr. The epidemiology of soft tissue sarcoma. Semin Oncol. 1997;24:504-514.
3. Fletcher CD, Rydholm A, Singer S, Sundaram M, Coindre JM. Soft tissue tumours: epidemiology, clinical features, histopathological typing and grading. In: Fletcher CD, Unni KK, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002:12-18.
4. Guo W, Xu W, Huvos AG, Healey JH, Feng C. Comparative frequency of bone sarcomas among different racial groups. Chin Med J (Engl). 1999;112:1101-1104.
5. Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst. 2002;94:1712-1718.
6. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer. 2000;88:500-517.
7. Stebbing J, Portsmouth S, Bower M. Insights into the molecular biology and sero-epidemiology of Kaposi's sarcoma. Curr Opin Infect Dis. 2003;16:25-31.
8. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204-1210.
9. Kim MK, Huh SJ, Kim DY, et al. Secondary angiosarcoma following irradiation - case report and review of the literature. Radiat Med. 1998;16:55-60.
10. Stewart FW, Treves N. Lymphangiosarcoma in post mastectomy lymphedema: a report of six cases of elephantiasis chirurgica. Cancer. 1948;1:64-68.
11. McClay EF. Epidemiology of bone and soft tissue sarcomas. Semin Oncol. 1989;16:264-272.
12. Levesque J, Bell RS, Coyte PC, Wright JG. Changing rates of cancer. The hazards of using a single definition. J Clin Epidemiol. 2001;54:225-231.
13. Pisters PW, Casper ES, Mann GN, O'Sullivan B. Soft-tissue sarcomas. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD, editors. Cancer management: a multidisciplinary approach, 7th ed. New York: PRR, Inc., 2003:559-584.
14. Lynch HT, McComb RD, Osborn NK, et al. Predominance of brain tumors in an extended Li-Fraumeni (SBLA) kindred, including a case of Sturge-Weber syndrome. Cancer. 2000; 88:433-439.
15. Lynch HT, Brand RE, Hogg D, et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical multiple mole melanoma-pancreatic carcinoma syndrome. Cancer. 2002;94: 84-96.
16. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet. 2003;33 Suppl:238-244.
17. David KL, Steiner-Grossman P. The potential use of tumor registry data in the recognition and prevention of hereditary and familial cancer. N Y State J Med. 1991;91:150-152.
18. Lynch HT. Cancer and the family history trail. N Y State J Med. 1991;91:145-147.
19. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001; 344:1052-1056.
20. Beghini A, Tibiletti MG, Roversi G, et al. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer. 2001;92:657-662.
21. Nishida T, Hirota S, Taniguchi M, et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet. 1998;19:323-324.
22. Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden JM. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol. 2000;157:1581-1585.
23. Hirota S, Nishida T, Isozaki K, et al. Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology. 2002;122: 1493-1499.
24. Polednak AP. Do physicians discuss genetic testing with family-history-positive breast cancer patients? Conn Med. 1998;62:3-7.
25. Cho MK, Sankar P, Wolpe PR, Godmilow L. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test. Am J Med Genet. 1999;83:157-163.
26. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997;336:823-827.
27. Wong N, Lasko D, Rabelo R, Pinsky L, Gordon PH, Foulkes W. Genetic counseling and interpretation of genetic tests in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Dis Colon Rectum. 2001;44:271-279.
28. Rabelo R, Foulkes W, Gordon PH, et al. Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families. Dis Colon Rectum. 2001;44:437-446.
29. Wideroff L, Freedman AN, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev. 2003;12:295-303.
30. Raskind WH, Conrad EU, Chansky H, Matsushita M. Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet. 1995;56:1132-1139.
31. Wuyts W, Van Hul W. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat. 2000; 15:220-227.
32. McNairn JD, Damron TA, Landas SK, Ambrose JL, Shrimpton AE. Inheritance of osteosarcoma and Paget's disease of bone: a familial loss of heterozygosity study. J Mol Diagn. 2001;3:171-177.
33. Hocking LJ, Lucas GJ, Daroszewska A, et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet. 2002;11:2735-2739.
34. Nellissery MJ, Padalecki SS, Brkanac Z, et al. Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am J Hum Genet. 1998;63:817-824.
35. Sparks AB, Peterson SN, Bell C, et al. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma. Calcif Tissue Int. 2001;68:151-155.
36. Hale LR, Kelly JW. Familial Kaposi's sarcoma and Paget's disease of bone. Australas J Dermatol. 1998;39:241-243.
37. Siris ES, Ottman R, Flaster E, Kelsey JL. Familial aggregation of Paget's disease of bone. J Bone Miner Res. 1991;6:495-500.
38. Miozzo M, Castorina P, Riva P, et al. Chromosomal instability in fibroblasts and mesenchymal tumors from 2 sibs with Rothmund-Thomson syndrome. Int J Cancer. 1998;77:504-510.
39. Wang LL, Gannavarapu A, Kozinetz CA, et al. Osteosarcoma in Rothmund-Thomson syndrome is associated with truncating mutations in the RECQL4 gene [abstract]. Proc Am Assoc Cancer Res. 2002;43:A3818.
40. Hillmann A, Ozaki T, Winkelmann W. Familial occurrence of osteosarcoma. A case report and review of the literature. J Cancer Res Clin Oncol. 2000;126:497-502.
41. Longhi A, Benassi MS, Molendini L, Macchiagodena M, Picci P, Bacci G. Osteosarcoma in blood relatives. Oncol Rep. 2001;8:131-136.
42. Kruzelock RP, Murphy EC, Strong LC, Naylor SL, Hansen MF. Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res. 1997;57:106-109.
43. Carney JA. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc. 1999;74:543-552.
44. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type 1-α regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26:89-92.
45. Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet. 2002;108:132-139.
46. Alonso J, Garcia-Miguel P, Abelairas J, Mendiola M, Pestana A. A microsatellite fluorescent method for linkage analysis in familial retinoblastoma and deletion detection at the RB1 locus in retinoblastoma and osteosarcoma. Diagn Mol Pathol. 2001;10:9-14.
47. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986; 53:661-671.
48. Li FP, Abramson DH, Tarone RE, Kleinerman RA, Fraumeni JF Jr., Boice JD Jr. Hereditary retinoblastoma, lipoma, and second primary cancers. J Natl Cancer Inst. 1997;89:83-84.
49. Eng C, Li FP, Abramson DH. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85:1121-1126.
50. Fuchs B, Pritchard DJ. Etiology of osteosarcoma. Clin Orthop. 2002;397:40-52.
51. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasm in patients with bilateral retinoblastoma. Ophthalmology. 1988;95:1583-1587.
52. Sonoda Y, Saigo PE, Federici MG, Boyd J. Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin. Gynecol Oncol. 2000;76: 226-229.
53. Tsuji Y, Kusuzaki K, Kanemitsu K, Matsumoto T, Ishikawa Y, Hirasawa Y. Calcaneal osteosarcoma associated with Werner syndrome. A case report with mutation analysis. J Bone Joint Surg Am. 2000;82:1308-1313.
54. Gray MD, Shen JC, Kamath-Loeb AS, et al. The Werner syndrome protein is a DNA helicase. Nat Genet. 1997;17: 100-103.
55. Nijhuis PH, Schaapveld M, Otter R, Molenaar WM, van der Graaf WT, Hoekstra HJ. Epidemiological aspects of soft tissue sarcomas (STS)-consequences for the design of clinical STS trials. Eur J Cancer. 1999;35:1705-1710.
56. Narita T, Dobashi Y, Nakamura T, Yokoyama S, Matsuda K. Familial aggregation of soft tissue sarcomas: a report of three cases from a Li-Fraumeni-like family. Arch Pathol Lab Med. 1997;121:493-498.
57. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr., Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90:606-611.
58. Frebourg T, Barbier N, Yan YX, et al. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet. 1995;56:608-615.
59. Schmutz JL, Kue E, Baylac F, Reichert- Penetrat S, Barbaud A. Angiosarcoma complicating Hallopeau-Siemens-type hereditary epidermolysis bullosa. Br J Dermatol. 1998;138:910-912.
60. Gardella R, Belletti L, Zoppi N, Marini D, Barlati S, Colombi M. Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa. Am J Hum Genet. 1996;59:292-300.
61. Gardner TL, Elston DM, Wotowic PJ. A familial dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1998;39:504-505.
62. Naeem R, Lux ML, Huang SF. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol. 1995;147:1553-1558.
63. Cerri A, Gianni C, Corbellino M, Pizzuto M, Moneghini L, Crosti C. Lymphangiosarcoma of the pubic region: a rare complication arising in congenital non-hereditary lymphedema. Eur J Dermatol. 1998;8:511-514.
64. Evans AL, Brice G, Sotirova V, et al. Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet. 1999;64:547-555.
65. Dahlberg PJ, Borer WZ, Newcomer KL. Autosomal or X-linked recessive syndrome of congenital lymphedema, hypoparathyroidism, nephropathy, prolapsing mitral valve, and brachytelephalangy. Am J Med Genet. 1983;16:99-104.
66. de Alava E, Kawai A, Healey JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol. 1998;16:1248-1255.
67. Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene. 2001;20:5747-5754.
68. Cerosaletti KM, Lange E, Stringham HM, et al. Fine localization of the Nijmegen breakage syndrome gene to 8q21: evidence for a common founder haplotype. Am J Hum Genet. 1998;63:125-134.
69. King A, DeBaun M, Riccardi V, Gutmann DH. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet. 2000;93:388-392.
70. Korf BR. Plexiform neurofibromas. Am J Med Genet. 1999; 89:31-37.
71. National Institutes of Health Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol. 1988;45:575-578.
72. Wang Q, Lasset C, Desseigne F, et al. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res. 1999;59:294-297.
73. Woodruff JM. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet. 1999; 89:23-30.
74. Barker D, Wright E, Nguyen K, et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science. 1987;236:1100-1102.
75. Cottoni E, Masala MV, Mulargia M, Contu L. Familial Kaposi's sarcoma: case reports and review of the literature. Acta Derm Venereol. 1996;76:59-61.
76. Kempf W, Perniciaro C, Adams V, Mueller B, Burg G. Human herpesvirus 8 (HHV-8) in familial Kaposi's sarcoma. Exp Dermatol. 1999;8:68-70.
77. Ash is present in non-Jewish Americans of Spanish ancestry. Am J Hum Genet. 1998;63:1685-1693.
78. German J, Ellis NA. Bloom syndrome. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill, 1998:301-315.
79. Gruber SB, Ellis NA, Scott KK, et al. BLM heterozygosity and the risk of colorectal cancer. Science. 2002;297:2013.
80. Kraemer BB, Silva EG, Sneige N. Fibrosarcoma of ovary. A new component in the nevoid basal-cell carcinoma syndrome. Am J Surg Pathol. 1984;8:231-236.
81. Farndon PA, Del Mastro RG, Evans DG, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet. 1992;339:581-582.
82. Martignetti JA, Desnick RJ, Aliprandis E, et al. Diaphyseal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/ cancer syndrome maps to 9p21-22. Am J Hum Genet. 1999;64:801-807.
83. Scott RJ, Froggatt NJ, Trembath RC, Evans DG, Hodgson SV, Maher ER. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet. 1996;5:1921-1924.
84. Clark SK, Neale JC, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg. 1999;86:1185-1189.